Significant Increase in Short Interest for Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

The Fidelity Disruptive Medicine ETF (NASDAQ:FMED) experienced a notable surge in short interest during February. By February 28th, the total short interest rose to 900 shares, reflecting a substantial increase of 125.0% from the 400 shares reported on February 13th. Currently, around 0.0% of the ETF's total shares are sold short. Given an average daily trading volume of 5,700 shares, the short-interest ratio stands at 0.2 days.

Institutional Investments in Fidelity Disruptive Medicine ETF

Recently, an institutional investor, Jane Street Group LLC, significantly increased its stake in the Fidelity Disruptive Medicine ETF. According to a recent 13F filing with the Securities and Exchange Commission (SEC), Jane Street Group raised its position in FMED by 200.4% during the third quarter. After acquiring an additional 40,924 shares, the firm now holds a total of 61,342 shares, representing about 2.92% of the ETF and valued at approximately $1,613,000 as of the end of the most recent reporting period.

Current Performance of Fidelity Disruptive Medicine ETF

As of Friday, FMED opened trading at $24.03. The ETF has recorded a 12-month low of $23.32 and a high of $26.79. It features a fifty-day simple moving average of $25.50 and a 200-day simple moving average of $25.70. The ETF's market capitalization is currently $50.46 million, with a P/E ratio of 42.34 and a beta of 0.94, indicating moderate volatility.

Quarterly Dividend Announcement

The Fidelity Disruptive Medicine ETF also recently announced an increase in its quarterly dividend, which was disbursed on December 24th. Shareholders as of December 20th received a dividend of $0.112, with this date marking the ex-dividend cut-off. This dividend corresponds to an annualized yield of 1.86%, representing a notable increase from the previous quarterly distribution of $0.00.

Overview of Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an actively managed exchange-traded fund (ETF) focused primarily on investing in healthcare equities. Launched on April 16, 2020, the fund targets companies that are actively engaged in disruptive innovations within the healthcare sector, thus diversifying investments across both domestic and foreign issuers.

Additional Reading

• Five stocks we like better than Fidelity Disruptive Medicine ETF
• Mastering Discipline: Overcoming Emotional Challenges in Trading
• Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
• Comparing and Trading High PE Ratio Stocks
• Casey’s Uptrend Remains Strong—New Highs on the Horizon
• How to Short a Stock in 5 Easy Steps
• Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead

Short, Interest, ETF